Company Filing History:
Years Active: 2007
Title: Joerg Koenig: Innovator in Transport Inhibitor Identification
Introduction
Joerg Koenig is a notable inventor based in Griesheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the identification of transport inhibitors. His innovative work has implications for drug development and therapeutic applications.
Latest Patents
Joerg Koenig holds a patent for a double-transfected cell line that is useful for the identification of transport inhibitors. This patent describes a double-transfected cell line containing a DNA sequence encoding an uptake transporter for organic anions, preferably OATP8, operatively linked with a promoter. Additionally, it includes a DNA sequence encoding an export pump for organic anions or anionic conjugates, preferably the multidrug resistance protein 2 (MRP2), also operatively linked with a promoter. The patent outlines various uses of this cell line, particularly its application in identifying transport inhibitors, such as potential drug candidates. He has 1 patent to his name.
Career Highlights
Joerg Koenig is associated with the German Cancer Research Center (Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts). His work at this prestigious institution has allowed him to focus on critical research that bridges the gap between basic science and clinical applications.
Collaborations
Throughout his career, Joerg has collaborated with esteemed colleagues, including Yunhai Cui and Dietrich Keppler. These collaborations have enriched his research and contributed to advancements in the field.
Conclusion
Joerg Koenig's innovative work in developing a double-transfected cell line for identifying transport inhibitors showcases his commitment to advancing biotechnology. His contributions are vital for the future of drug development and therapeutic strategies.